More than two years after Medicare's revised Conditions for Coverage (CfC) for ambulatory surgery centers (ASCs) went into effect, some endoscopy ASCs still have questions about the best ways to comply with the new infection control standards.
Join the Association for Professionals in Infection Control and Epidemiology (APIC) for "Meeting CMS Requirements for Coverage on Infection Control at Ambulatory Endoscopy Centers," an hour-long webinar on Wednesday, Sept. 28, at 1 pm. Ambulatory Surgery Center Association (ASCA) members can register for free.
Laura Strohmeyer, AmSurg regional director of GI clinical services division III, will review the applicable CMS CfC infection control standards, discuss common deficiencies cited,a nd identify strategies that can be used to promote a successful CMS survey.
Register now at webinars.apic.org. Learn about ASCA's 2011 webinar series at ascassociation.org/webinars. Â
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.